Peak Bio, Inc. Warrant
PKBOW
PKBOW was delisted on the 5th of January, 2023.
0 hedge funds and large institutions have $0 invested in Peak Bio, Inc. Warrant in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 5 closing their positions.
100% less funds holding
Funds holding: 5 → 0 (-5)
100% less capital invested
Capital invested by funds: $28K → $0 (-$28K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EFI
EHP Funds Inc
Toronto,
Canada
|
-$25K |
| 2 |
CCM
Context Capital Management
Lajolla,
California
|
-$3K |
| 3 |
CS
Clear Street
New York
|
-$3 |
PKBOW Hedge Fund Activity: Q2 2023 in Review
0 of the 6,385 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Warrant (PKBOW) for Q2 2023, worth a combined $0 — down 100% from $28K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PKBOW and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was EHP Funds Inc, exiting entirely with an estimated $25K sold.
- 0 institutional investors held Peak Bio, Inc. Warrant (PKBOW) as of Q2 2023, down from 5 in Q1 2023.
- Funds reported $0 of Peak Bio, Inc. Warrant stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new Peak Bio, Inc. Warrant positions in Q2 2023 and 5 closed out, a net change of -5 holders.
- The largest Peak Bio, Inc. Warrant seller in Q2 2023 was EHP Funds Inc, an estimated $25K sold.
Based on aggregated 13F filings for Q2 2023.